Antithrombotic Drugs Market to Reach $105.33 Billion by 2032, Growing at an 8.1% CAGR

𝐈𝐧 𝟐𝟎𝟐𝟒, 𝐭𝐡𝐞 𝐚𝐧𝐭𝐢𝐭𝐡𝐫𝐨𝐦𝐛𝐨𝐭𝐢𝐜 𝐝𝐫𝐮𝐠𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 𝐔𝐒𝐃 𝟓𝟐.𝟑𝟒 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏𝟎𝟓.𝟑𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒, 𝐮𝐩 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟓𝟔.𝟓𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟓, 𝐬𝐡𝐨𝐰𝐜𝐚𝐬𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟖.𝟏% 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝟐𝟎𝟐𝟓 𝐚𝐧𝐝 𝟐𝟎𝟑𝟒. 𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐫𝐞𝐬𝐩𝐨𝐧𝐬𝐢𝐛𝐥𝐞 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

• It is expected that the rise in antithrombotic/anticoagulant drug use, an increasing older population, and a surge in thrombotic occurrences are propelling the antithrombotic market.

• As a growing number of individuals with diabetes face an increased risk of developing cardiovascular disease, the demand for antithrombotic medications is expected to rise, fueling market growth.

• As the number of individuals with diabetes at elevated risk for developing cardiovascular disease continues to rise, the demand for antithrombotic medications is expected to grow, leading to market growth.

• Supportive reimbursement policies and the underactive lifestyles of individuals would enhance the market's growth rate.

𝐖𝐡𝐚𝐭 𝐀𝐫𝐞 𝐀𝐧𝐭𝐢𝐭𝐡𝐫𝐨𝐦𝐛𝐨𝐭𝐢𝐜 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬?
Antithrombotic drugs are a class of medications that prevent and treat blood clots, also known as thrombi. They are commonly prescribed to treat cardiovascular conditions. There are three main types of antithrombotic medications, namely Anticoagulants (minimize clotting by reducing fibrin formation), Antiplatelet agents (prevent clumping of platelets), and Thrombolytic drugs (dissolve existing clots). They are used to prevent and treat deep vein thrombosis, prevent and treat pulmonary embolism, and prevent arterial embolism in patients with atrial fibrillation. Older people may be more vulnerable to the adverse effects of antithrombotic drugs, such as bleeding or drug-drug interaction.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/request-for-sample

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭
There are numerous local or regional competitors in the fiercely competitive landscape of the antithrombotic drugs market. A few of the key players influencing the market are:

• Bristol-Myers Squibb Company
• AstraZeneca plc
• Eli Lilly and Company
• C.H. Boehringer Sohn AG & Ko. KG
• Aspen Bayer AG
• Pfizer
• Johnson & Johnson
• AstraZeneca
• Otsuka Pharmaceutical
• Portola Pharmaceutical Inc.

𝐀𝐧𝐭𝐢𝐭𝐡𝐫𝐨𝐦𝐛𝐨𝐭𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• Antiplatelet drugs are expected to dominate the market due to increasing use for clotting as arterial clots comprised primarily of platelets, antiplatelet medications are most effective.

• Activities by key players in the market for the development of antiplatelet drugs are expected to drive the market growth over the forecast period.

• Anticoagulant, Thrombolytic, and oral drugs is expected to hold the largest market share during the forecast period. Anticoagulants work by interfering with several blood coagulation pathways, making them closely connected to antiplatelet medications and thrombolytic therapies.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/request-for-discount-pricing

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
• The market for antithrombotic drugs is segmented based on route of administration, drug type, end user, application, and region.
• Based on drug type, the antithrombotic drugs market is segmented as antiplatelet drugs, anticoagulant drugs, and thrombolytic drugs.
• The antiplatelet segment captured the largest revenue share of the market in 2022 since they are used as first-line antithrombotic therapy for acute ischemic syndrome and avoid their recurrence.
• The market, based on the route of administration, is segmented as parenteral and oral.
• The oral route of administration captured the largest market share in 2022 as they are usually the first choice of treatment.

Antithrombotic Drugs market, By Drug Type (Revenue - USD Billion, 2019-2032)
• Antiplatelet Drug
• Anticoagulant Drug
• Thrombolytic Drug

Antithrombotic Drugs market, By Route of Administration (Revenue - USD Billion, 2019-2032)
• Oral
• Parenteral

Antithrombotic Drugs market, By Application (Revenue - USD Billion, 2019-2032)
• Pulmonary Embolism
• Deep Vein Thrombosis
• Atrial Fibrillation
• Others

Antithrombotic Drugs market, By End User (Revenue - USD Billion, 2019-2032)
• Hospitals
• Ambulatory Surgery Centres
• Emergency Service Centres
• Others

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/analysis-type

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬
Antithrombotic Drugs Market, Regional Outlook (Revenue - USD Billion, 2019-2032)
• North America
o Drug Type Outlook
 Anticoagulant Drug
 Antiplatelet Drug
 Thrombolytic Drug
o Route of Administration Outlook
 Oral
 Parenteral
o Application Outlook
 Pulmonary Embolism
 Deep Vein Thrombosis
 Atrial Fibrillation
 Others
o End User Outlook
 Hospitals
 Emergency Service
 Centres
 Ambulatory Surgery Centres
 Others

• Europe
o Drug Type Outlook
 Anticoagulant Drug
 Antiplatelet Drug
 Thrombolytic Drug
o Route of Administration Outlook
 Oral
 Parenteral
o Application Outlook
 Pulmonary Embolism
 Deep Vein Thrombosis
 Atrial Fibrillation
 Others
o End User Outlook
 Hospitals
 Emergency Service
 Centres
 Ambulatory Surgery Centres
 Others

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Chemiluminescence Immunoassay Market
https://www.polarismarketresearch.com/industry-analysis/chemiluminescence-immunoassay-market

Ostomy/Stoma Care Market
https://www.polarismarketresearch.com/industry-analysis/ostomy-care-market

Mesenchymal Stem Cells Market
https://www.polarismarketresearch.com/industry-analysis/mesenchymal-stem-cells-market

Myasthenia Gravis Disease Market
https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.